Tag Archives: Cure Disease

Former Dexcom Exec Claudia Graham Joins StartUp Health’s New T1D Moonshot Impact Board

August 9, 2022Business, Health, Innovation, StartupsClaudia Graham, Cure Disease, Dexcom, diabetes, Diabetes Moonshot, Health Moonshots, StartUp Health, Type 1 Diabetes, Type 1 Diabetes MoonshotNicole Kinsey

Podcast: Play in new window | Download (Duration: 17:19 — 23.8MB)

“The more you know, the better you’ll do living with diabetes,” says Claudia Graham. “There’s nothing more important in diabetes than empowering patients.”

If you follow StartUp Health at all, you have seen headlines about our new Type 1 Diabetes Moonshot. To recap, we’ve launched an initiative designed to speed up innovation around Type 1 diabetes by bringing together a cross-disciplinary team of investors, entrepreneurs, philanthropists, researchers, and other industry experts. At the heart of the effort is an Impact Board – basically our T1D dream team – which brings together the top minds in the field for collaborative working sessions. We wanted to take some time on this podcast to introduce you to some of the inspiring folks on this Impact Board and invite you to get involved in the effort.

On this episode you’ll meet Claudia Graham, former executive at Dexcom, the company that revolutionized the continuous glucose monitor. She served as VP of Marketing and SVP of Global Access. Now she’s putting her decades of experience at Dexcom – and as someone living with Type 1 diabetes – to work as an advisor and investor. We caught up with Claudia over zoom at her home in Idaho to learn about the opportunities and challenges she sees in the Type 1 Diabetes Moonshot, how StartUp Health helps get away from institutional thinking to break down barriers and empower patients, and how she thinks about leaving a legacy for the next generation.

Entrepreneurs, are you working on a T1D solution? We want to hear from you.
Investors, want to back an impact-driven fund laser focused on T1D? Contact us.

Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Health Transformers Live: Gray Oncology Solutions, Gennev, AvoMD, Valera Health

April 5, 2022Business, Health, Innovation, Insights, Startups2022 StartUp Health Festival, Access to care, Cancer, Cure Disease, End Cancer, Health Moonshots, Lauren Schafer, mental health, Moonshots, StartUp Health @ ViVE, StartUp Health Festival, ViVE 2022, ViVE Miami, womens healthNicole Kinsey

Podcast: Play in new window | Download (Duration: 19:29 — 17.9MB)

This week we wanted to break from our typical format and introduce you to four inspiring founders from the StartUp Health portfolio.

This episode is excerpted from an on-stage Health Transformer discussion that was held at the StartUp Health Festival @ ViVE in Miami Beach in March. You’ll hear from André Diamant, PhD, CEO & Founder of Gray Oncology Solutions, about how they’re improving efficiency in cancer care. Jill Angelo, CEO & Founder of Gennev, talks about how they’re improving women’s health in their post-reproductive years. Yair Saperstein, MD, CEO & Co-founder of AvoMD, explains how they’re crowdsourcing knowledge in order to put the best decision support tools in the palm of the physician’s hand. And finally, Tom Tsang, MD, CEO & Co-founder of Valera Health, explains how his company is bringing comprehensive mental health services to the virtual healthcare ecosystem.

The session was hosted by Lauren Schafer from StartUp Health. In addition to sharing the moonshot missions of each of their companies, they talk about changes seen in health innovation due to COVID’s impact, their biggest messages for partners and investors, and more.

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

Investors: How to invest in StartUp Health Moonshots healthmoonshots.com
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

How Nightingale Is Redefining Preventative Health

February 8, 2022Business, Health, Innovation, Insights, Startups, UncategorizedAI, Blood Testing, Cure Disease, diabetes, Finland, Health Moonshot Update, Health Moonshots, Health Tech, Heart Disease, Logan Plaster, Longevity, Moonshots, Nightingale, Teemu Suna, TelehealthNicole Kinsey

Podcast: Play in new window | Download (Duration: 39:50 — 36.5MB)

Join us in Miami Beach in March for StartUp Health @ ViVE 2022: startuphealth.com/vive

Nightingale Health, a Finnish company that StartUp Health backed in 2016, uses a new kind of blood testing to predict future disease risk so that people can change the course of their health before it’s too late. They’ve designed a way to analyze blood samples that pulls 250 times more data from that sample than a typical test. They use artificial intelligence and machine learning to correlate that data with future disease risk, like diabetes and heart disease. Then they put the result in simple terms so that patients can see trends and take action.

This year, Nightingale took three big strides forward. They went public on the Finnish Nasdaq, which gave them capital to scale globally. They rolled out at-home testing kits so more people can benefit from Nightingale’s disease prediction. And they acquired a genomics company that will allow them to bake genetic information into their app and provide people with even more personalized health assessments.

We sat down with Nightingale CEO and Co-founder Teemu Suna to hear more about their blood testing technology and how it could change preventative health globally by getting patients to see their potential future and then change the course of their health.

Join us in Miami Beach in March at StartUp Health @ ViVE 2022 to meet Health Transformers: startuphealth.com/vive

—

Learn more and connect with the team at Nightingale.

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

Responsum Health’s Latest App Puts Long-COVID Front and Center

January 10, 2022Business, Health, Innovation, Insights, Startups, UncategorizedAccess to care, coronavirus, Covid, Covid 19, COVID19, Cure Disease, Health Moonshot Update, Health Moonshots, Logan Plaster, Pandemic Response, Responsum HealthNicole Kinsey

Podcast: Play in new window | Download (Duration: 21:14 — 19.5MB)

Our guest today is Andrew Rosenberg, CEO and Founder of Responsum Health, which StartUp Health backed in 2019. At Responsum, Rosenberg and his team have created disease-specific apps that bring together curated information and news about that disease as well as a professionally-moderated community chat, so patients can connect and learn in a safe environment. Their recent app developed around Long-COVID has exploded with activity, so we sat down with Rosenberg to hear what he’s learning from this community of patients.

Join us in Miami Beach in March at StartUp Health @ ViVE 2022 and meet Andrew Rosenberg and other Health Transformers: startuphealth.com/vive

—

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

Reversing Diabetes With Sami Inkinen of Virta Health

January 4, 2022Business, Health, Innovation, Insights, StartupsCure Disease, diabetes, Health Moonshot Update, Health Moonshots, Logan Plaster, Moonshots, Sami Inkinen, Type 2 Diabetes, Type II Diabetes, Virta, Virta HealthNicole Kinsey

Podcast: Play in new window | Download (Duration: 36:58 — 50.8MB)

Join us in Miami Beach from March 6-9, 2022, for StartUp Health @ ViVE to meet Health Transformers: startuphealth.com/vive

The numbers surrounding Type 2 diabetes are staggering. The WHO puts the number north of 400 million people globally, and it’s just getting worse. Health experts agree that Type 2 diabetes can largely be managed by a combination of nutrition, exercise, and medication. But what if it could be reversed completely? That’s the claim, and the health moonshot, of our guest today, Sami Inkinen, CEO and Founder of Virta, which StartUp Health backed in 2020. Specifically, Inkinen and his team want to reverse Type 2 diabetes in 100 million people by 2025.

Before Virta, Inkinen disrupted the real estate industry by co-founding Trulia, which he sold to Zillow for $2.5B. Now with Virta, he’s raised more than $350M to date, giving him the capital needed to take a great idea and scale it in unprecedented ways.

—

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

For Ironman Athlete David Weingard, a Diabetes Diagnosis Was a Spark for Innovation

November 30, 2021Business, Health, Innovation, Insights, Startups, UncategorizedAccess to care, Cecelia Health, Cure Disease, David Weingard, diabetes, Health Moonshot Update, Health Moonshots, Logan Plaster, Startup, StartUp HealthStartUp Health NOW

Podcast: Play in new window | Download (Duration: 36:42 — 50.4MB)

Join us in Miami Beach from March 6-9, 2022, for StartUp Health @ ViVE to meet the Cecelia Health team and other Health Transformers: startuphealth.com/vive

===

Today, you’d be hard-pressed to find anyone who hasn’t been impacted by diabetes in some way. Globally, half a billion people are affected by the disease, and it was responsible for the deaths of 1.5M people globally in 2019. As frightening as those numbers are, there is also great hope to be found today in the entrepreneurs and innovations changing how we manage diabetes. To understand both sides of this coin – the very personal toll of diabetes plus the present and future promise of health technology – we talked to David Weingard, founder of Cecelia Health, which helps diabetics get the specialized health coaching they need. More importantly, David is a type 1 diabetic who has fought for his own life and knows the daily fears and challenges that this silent disease brings to millions. It’s that combination of experience that makes David’s journey so powerful.

===

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

Investors: How to invest in StartUp Health Moonshots healthmoonshots.com
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Sales Strategies With Reed Mollins and Brian Neman

September 14, 2021Business, Health, Insights, Startups, UncategorizedAccess to care, Brian Neman, Cure Disease, doctor.com, Katya Hancock, Press Ganey, reed mollins, Sanguine Biosciences, StartUp HealthStartUp Health NOW

Podcast: Play in new window | Download (Duration: 42:57 — 39.3MB)

This week on the podcast we get tactical with two founders from the StartUp Health portfolio to talk about sales strategies. Our first guest is Reed Mollins, the VP of Strategic Partnerships at Press Ganey. Mollins is well known in our community for co-founding Doctor.com and scaling it over most of a decade before being acquired by Press Ganey last year. Our second guest is Brian Neman, the CEO & Founder of Sanguine Biosciences. Brian built his clinical trials platform from zero to eight-figure revenue today.

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

Aidar Health Scores FDA Clearance for New Breath-Based “Tricorder” Health Monitoring Device

March 23, 2021Business, Health, Innovation, Startups, UncategorizedAccess to care, Cure Disease, Logan Plaster, Pandemic ResponseStartUp Health NOW

Podcast: Play in new window | Download (Duration: 25:04 — 34.4MB)

In this episode, we talk with Sathya Elumalai, CEO & Co-founder of Aidar Health, a StartUp Health company since 2016. Sathya and his team in Baltimore have invented something that could change healthcare as we know it. It’s a simple-looking device that you hold in your hand and breathe into for 30 seconds. From that simple act, the device — MouthLab — can pull more than 10 vitals. What’s even more impressive is that they’ve clinically validated the health tests at the highest level. Sathya breaks it all down in our interview and explains his moonshot vision for the future of remote monitoring and chronic disease management.

Entrepreneurs: How to get investment from StartUp Health startuphealth.com
Investors: How to invest in StartUp Health Moonshots healthmoonshots.com

Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

GE Healthcare’s Karley Yoder Builds Bridges With AI

March 16, 2021Business, Health, Innovation, Startups, UncategorizedAccess to care, Cost to Zero, Cure Disease, GE, karley yoder, Logan PlasterStartUp Health NOW

Podcast: Play in new window | Download (Duration: 56:39 — 77.8MB)

Karley Yoder made a name for herself in the digital health world at Doctor on Demand and Apple before launching a career at GE Healthcare, where she now serves as Vice President and General Manager of Artificial Intelligence. Today, she works to find the signal in the noise surrounding AI, helping the company leverage its potential to improve patient outcomes, rather than to apply, as she puts it, “technology for technology’s sake.” Yoder joined the StartUp Health community at a recent Fireside Chat, where she explained how impact-driven AI can help to expand care teams, why effective partnerships are built on practical approaches to problems, and how an ecosystem of “GE-plus-others” can help ensure positive, sustainable change.

Entrepreneurs: How to get investment from StartUp Health startuphealth.com
Investors: How to invest in StartUp Health Moonshots healthmoonshots.com

Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Conversa Health Built on Its Virtual Care Platform to Quickly Launch COVID-19 Screening Tools for Frontline Workers

December 8, 2020UncategorizedAccess to care, coronavirus, Cost to Zero, Covid 19, COVID19, Cure Disease, Logan Plaster, Pandemic ResponseStartUp Health NOW

Podcast: Play in new window | Download (Duration: 49:30 — 68.0MB)

Today’s episode is a conversation with Murray Brozinsky, CEO of Conversa Health. Before COVID-19 struck, Conversa was working with big health systems, supplying them with a type of chatbot that kept patients and doctors connected between appointments. Turns out a few well-worded and well-timed questions, even if they’re automated, can improve care and reduce costly bouncebacks. When COVID-19 hit, Murray and his team knew they had the technology – and institutional relationships – to really make a difference. They quickly scaled up multiple COVID-specific products using automated chat and have seen massive growth in 2020 as a result. This conversation with Murray is pulled from a recent Expert Office Hour, which was attended virtually by an audience of other founders from the StartUp Health portfolio. We dug into how Conversa was able to stay nimble and grow in spite of uncertainty, and other Health Transformers weigh in with their thoughts as well.

Entrepreneurs: How to get investment from StartUp Health startuphealth.com
Investors: How to invest in StartUp Health Moonshots healthmoonshots.com

Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.